City Clinical Hospital No. 1, Kiev

Kiev 2091

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Myocardial Infarction

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed